These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

112 related items for PubMed ID: 18094597

  • 1. [Evaluation of Viva-E drug testing system].
    Chung HS, Lee ST, Lee SY.
    Korean J Lab Med; 2007 Oct; 27(5):330-7. PubMed ID: 18094597
    [Abstract] [Full Text] [Related]

  • 2. Therapeutic drug monitoring on COBAS INTEGRA 400--evaluation results.
    Domke I, Cremer P, Huchtemann M.
    Clin Lab; 2000 Oct; 46(9-10):509-15. PubMed ID: 11034537
    [Abstract] [Full Text] [Related]

  • 3. Comparability and imprecision of 8 frequently used commercially available immunoassays for therapeutic drug monitoring.
    Shipkova M, Petrova DT, Rosler AE, Orth M, Engelmayer J, Wieland E, Brandhorst G, Oellerich M.
    Ther Drug Monit; 2014 Aug; 36(4):433-41. PubMed ID: 24646729
    [Abstract] [Full Text] [Related]

  • 4. Therapeutic drug monitoring and drugs of abuse testing on the cobas 6000 analyzer series: analytical performance under routine-like conditions.
    Brandhorst G, Luthe H, Domke I, Knoke C, Rhode KH, Sauter H, Oellerich M.
    Clin Chem Lab Med; 2009 Aug; 47(7):854-9. PubMed ID: 19496737
    [Abstract] [Full Text] [Related]

  • 5. Improved sensitivity for methotrexate analysis using enzyme multiplied immunoassay technique on the Siemens Viva-E instrument.
    Borgman MP, Hiemer MF, Molinelli AR, Ritchie JC, Jortani SA.
    Ther Drug Monit; 2012 Apr; 34(2):193-7. PubMed ID: 22377747
    [Abstract] [Full Text] [Related]

  • 6. Analyses of the pattern of therapeutic drug monitoring in a university hospital laboratory. Suitability and performance of the CEDIA assays.
    Hänseler E, Bigler S, Wad N.
    Wien Klin Wochenschr Suppl; 1992 Apr; 191():23-6. PubMed ID: 1509748
    [Abstract] [Full Text] [Related]

  • 7. The EMIT 2000 tacrolimus assay: an application protocol for the Beckman Synchron LX20 PRO analyzer.
    LeGatt DF, Shalapay CE, Cheng SB.
    Clin Biochem; 2004 Nov; 37(11):1022-30. PubMed ID: 15498532
    [Abstract] [Full Text] [Related]

  • 8. Evaluation of Cobas Integra 800 under simulated routine conditions in six laboratories.
    Redondo FL, Bermudez P, Cocco C, Colella F, Graziani MS, Fiehn W, Hierla T, Lemoël G, Belliard A, Manene D, Meziani M, Liebel M, McQueen MJ, Stockmann W.
    Clin Chem Lab Med; 2003 Mar; 41(3):365-81. PubMed ID: 12705348
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. The V-twin system (Dade Behring Laboratories): a useful tool for immunosuppressive drug monitoring.
    Elaerts S, Olejnik Y, Bonardet A, Garrigue V, Mourad G, Cristol JP, Dupuy AM.
    Transplant Proc; 2005 Mar; 37(1):167-71. PubMed ID: 15808583
    [Abstract] [Full Text] [Related]

  • 12. Evaluation of analytical methods and workflow performance of the Architect ci8200 integrated serum/plasma analyzer system.
    Hubl W, Zogbaum M, Boyd JC, Savory J, Schubert M, Meyer D, Demant T.
    Clin Chim Acta; 2005 Jul 01; 357(1):43-54. PubMed ID: 15963793
    [Abstract] [Full Text] [Related]

  • 13. Adaptation of EMIT drug assays to a random-access automated clinical analyzer.
    Boyd JC, Savory MG, Margrey M, Herold DA, Shipe JR, Savory J.
    Ann Clin Lab Sci; 1985 Jul 01; 15(1):39-44. PubMed ID: 3882047
    [Abstract] [Full Text] [Related]

  • 14. Development and evaluation of a simulation procedure to take into account various assays for the Bayesian dose adjustment of tacrolimus.
    Saint-Marcoux F, Debord J, Parant F, Labalette M, Kamar N, Rostaing L, Rousseau A, Marquet P.
    Ther Drug Monit; 2011 Apr 01; 33(2):171-7. PubMed ID: 21383655
    [Abstract] [Full Text] [Related]

  • 15. Reliability of mycophenolic acid monitoring by an enzyme multiplied immunoassay technique.
    Martiny D, Macours P, Cotton F, Thiry P, Gulbis B.
    Clin Lab; 2010 Apr 01; 56(7-8):345-53. PubMed ID: 20857899
    [Abstract] [Full Text] [Related]

  • 16. Preliminary observations on the Quality Assurance Service Therapeutic Drug Monitoring Program.
    Lohff MR.
    Am J Clin Pathol; 1980 Oct 01; 74(4 Suppl):542-5. PubMed ID: 7435445
    [Abstract] [Full Text] [Related]

  • 17. Evaluation of BD Barricor™ and PST™ blood collection tubes compared to serum for testing 11 therapeutic drugs on a Roche Cobas® 8000 platform.
    Jordan A, Sherazi A, Stevens A, Quondam Franks C, Sturgeon K, Northrup V, Shea JL.
    Clin Biochem; 2022 Feb 01; 100():60-66. PubMed ID: 34788637
    [Abstract] [Full Text] [Related]

  • 18. Calcineurin Inhibitor Determination in Whole Blood With the RXL Dimension Analyzer: A Useful Tool for Immunosuppressive Drug Monitoring.
    Ventura E, Bonardet A, Pageaux GP, Mourad G, Cristol JP.
    Transplant Proc; 2009 Mar 01; 41(2):707-9. PubMed ID: 19328963
    [Abstract] [Full Text] [Related]

  • 19. Liquid chromatographic analysis of phenobarbital, phenytoin, and theophylline.
    Hannak D, Haux P, Scharbert F, Kattermann R.
    Wien Klin Wochenschr Suppl; 1992 Mar 01; 191():27-31. PubMed ID: 1509749
    [Abstract] [Full Text] [Related]

  • 20. An introduction to drug testing: the expanding role of mass spectrometry.
    Hammett-Stabler C, Cotten SW.
    Methods Mol Biol; 2012 Mar 01; 902():1-13. PubMed ID: 22767103
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.